Immunic, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Net Income | $-52.1M | $-41.0M | $-52.0M | $-47.7M | $-32.7M | $-6.7M |
| Depreciation & Amortization | $998.0K | $1.8M | $1.3M | $1.1M | $799.0K | $651.0K |
| Depreciation | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — |
| Stock-Based Compensation | $5.5M | $4.7M | $4.0M | $2.5M | $948.0K | $144.0K |
| Net Cash from Operating Activities | $-40.4M | $-35.8M | $-50.0M | $-40.8M | $-28.6M | $-9.2M |
| Investing Activities | ||||||
| Capital Expenditures | $685.0K | $556.0K | $2.3M | $1.4M | $1.5M | $261.0K |
| Business Acquisitions | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-678.0K | $-21.0K | — | — | — | — |
| Financing Activities | ||||||
| Dividends Paid | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — |
| Net Cash from Financing Activities | $38.0M | $12.4M | — | — | — | — |
| Net Change in Cash | $-3.1M | $-23.4M | $-18.8M | $64.1M | $33.7M | $3.7M |
| Free Cash Flow | $-41.1M | $-36.3M | $-52.3M | $-42.2M | $-30.1M | $-9.5M |